QLT Inc. announces that it has completed sale of verteporfin for injection (Visudyne) to Valeant Pharmaceuticals International Inc.
Welcome to ModernMedicine
A scientific research grant to cover studies related to dry eye and ocular surface disease will be awarded by CLAO ERF in association with the SSF.
Certain eye movement patterns seem to be associated with better face recognition performance in patients with central glaucomatous visual field loss.
AcuFocus Inc. has received approval from Health Canada to market and sell the Kamra inlay, an innovative corneal inlay to treat presbyopia, within Canada.
The FDA has granted additional labeling indications for besifloxacin ophthalmic suspension 0.6% (Besivance, Bausch + Lomb).
A study provides new insight on the risk of early ocular surface-related complications among patients undergoing CXL for keratoconus.
The iDesign aberrometer (Abbott) provides an advanced, high-definition measurement device for wavefront-guided LASIK procedures.
The AcrySof IQ ReSTOR +2.5-D IOL offers sharp distance vision with an additional range of vision beyond a standard monofocal lens.
In today's blog from ESCRS, Mark Dlugoss, Ophthalmology Times editor-in-chief, discusses ophthalmic technologies and FDA-related availability issues.
The company promotes two and adds another employee as it names three vice presidents.